Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant Newcastle disease viruses and uses thereof for the prevention of RSV disease or human metapneumovirus disease

Recombinant Newcastle disease viruses and uses thereof for the prevention of RSV disease or human metapneumovirus disease

US Patent 12391957 · Granted Aug 19, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mosaic influenza virus hemagglutinin polypeptides and uses thereof2025
Mosaic influenza virus hemagglutinin polypeptides and uses thereof2025
Influenza virus hemagglutinin proteins and uses thereof2025
Influenza virus hemagglutinin proteins and uses thereof2025
Newcastle disease viruses and uses thereof2024
Newcastle disease viruses and uses thereof2024
Anti-influenza B virus neuraminidase antibodies and uses thereof2024
Anti-influenza B virus neuraminidase antibodies and uses thereof2024
Influenza virus hemagglutinin proteins and uses thereof2024
Influenza virus hemagglutinin proteins and uses thereof2024
Type I and type III interferon fusion molecules and methods for use thereof2022
Influenza virus hemagglutinin proteins and uses thereof2022